The Clinical Laboratories Were Not Recognized As Their Training

Total Page:16

File Type:pdf, Size:1020Kb

The Clinical Laboratories Were Not Recognized As Their Training Chapter Th e Clinical Laboratories (Chemistry and Hematology) Donna MacMillan and Kent B. Lewandrowski he clinical laboratories (Clinical millions of tests per year with a menu of over TChemistry and Hematology) at the Mas- 1,500 diff erent tests (including those sent to out- sachusetts General Hospital (MGH) originated side reference laboratories), and with oversight with individual physicians interested in specifi c of all point-of-care testing as well. Th is chap- diseases for which biological and therapeutic ter traces the transition from the earliest docu- clues began to emerge from laboratory tests. mented times to the present day. Over time, custom tests developed for specifi c patients were repeated for patients with similar The Early Years symptoms; in this way laboratory tests progres- Clinical laboratories had a minimal role in sively moved from research to patient care. the early years of the hospital: “For the fi rst sev- Th e chemistry laboratory at MGH has a long enty-fi ve years of its life there was nothing really history. It began as a central facility but was worthy [of] the name of a laboratory. Impor- quickly accompanied by a group of independent tant work was carried out in a hole-and-corner specialty laboratories such as the Th yroid, Endo- way” (1). Even by 1872 the laboratory measured crine and Metabolism, Blood Gases, and Lipid only approximately 6 by 10 feet. Located on the Laboratories, which led to a decentralized and ground fl oor of the Bulfi nch Building, it was complex set of separate facilities. On the other described as a “small dark room used as a labo- hand, there is little mention of hematology as a ratory where specimens of urine were taken for laboratory science until the middle of the twenti- analysis” (2) (fi gure 20.1). Testing was performed eth century. For much of their history, therefore, by the house pupils (medical students) as part of the clinical laboratories were not recognized as their training. a unique specialty or operation: even as late as In 1851 Dr. John Bacon Jr. was appointed the the middle of the second half of the twentieth fi rst Chemist-Microscopist for the hospital. He century, the clinical laboratories were not iden- had graduated from Harvard Medical School tifi ed as a separate and distinct service. Th e last (HMS) in the class of 1840, and he was known two decades have witnessed progressive consoli- from his early years as a gentleman with a bent dations, resulting in centralization of laboratory for mechanics. While in Europe after graduation, services, although the recent emergence of point- he developed an interest in chemistry. Upon his of-care testing has moved some testing back to return, he quickly built a career around analytic the bedside. As a result, the present confi guration techniques. He was known for maintaining an is primarily that of a single large Core Labora- organized private laboratory with the highest tory in the department of Pathology, performing quality reagents, and his primary expertise was 280 pathology_chap20.indd 280 8/16/11 10:23 AM The Clinical Laboratories (Chemistry and Hematology) preparing specimens for crystal identifi cation. Dr. Consultants in Chemistry (chapter 1), Dr. James Bacon’s appointment to the MGH staff allowed C. White (1863–1872) and Dr. Edward S. Wood him to expand his activities and his reputation as (1872–1905), also had responsibilities at HMS. an authority on analytic chemistry (1). In making In 1893 the laboratories were described as “a this appointment, the Trustees were recognizing little den fi tted up under the front steps, and the early contributions of chemistry and micros- unfi t for human occupation; partly in the nurses’ copy to clinical practice and research: “Micros- rooms connected with the wards; partly at the copy and organic chemistry are now considered Medical School, a mile away; partly at the patho- legitimate specialties and a few among our most logical room in the department of out-patients” promising and intelligent medical men devote (1). In 1896 the new Clinico-Pathological Labo- themselves entirely to these interesting studies” ratory (chapter 3) was established in the Allen (1). Even after Dr. Bacon established a formal Street Building and included a chemistry labora- laboratory at the MGH, however, many physi- tory on the third fl oor. A separate house offi cer’s cians continued to do their own laboratory work laboratory for patient testing was located on the for their patients. second fl oor. Th e fi rst annual report from the In the mid-1860s the roles of Chemist and laboratory describes the facility as a model labo- Microscopist were divided, and Dr. Bacon’s title ratory for providing training opportunities. Dr. changed to Chemist. He served in this role until Franz Pfaff (chapter 3) was appointed Chemist in 1863, when he resigned because of illness and his 1897 and put in charge of the Chemistry Labora- growing workload at HMS as Professor of Chem- tory in 1898, but much of the laboratory work istry. He died in Boston in 1881, at the age of 64. was still performed by house offi cers. From 1863 to 1897 the role of Chemist changed In the early 1890s Drs. William Gannett and to that of Consultant in Chemistry. Th e next two Richard C. Cabot (house offi cer from 1893 to Figure 20.1 Bulfi nch Building fl oor plan, 1872, with the laboratory (C) highlighted 281 pathology_chap20.indd 281 8/16/11 10:23 AM Keen Minds to Explore the Dark Continents of Disease 1894) started their work in the fi eld of hematol- patient and of using laboratory data to monitor a ogy (considered a medical specialty that included patient’s progress. In 1907 he wrote: examination of blood for malarial parasites) by When I see statements of blood counts which counting white cells in their patients’ blood spec- tell us, for example, that the patient had 5,633 imens. William Gannett (chapter 1) was born in leucocytes to the cubic millimeter, I cannot Boston in 1853, a descendent of John Winslow, help making two comments. First, that the one of the leaders of Plymouth Colony. He degree of accuracy to which the statement entered HMS in 1874 and was the fi rst student pretends is wholly useless; and second, that it to extend his studies to a fourth year for post- is only the pretense of accuracy after all. It is graduate work. During this year Gannett worked pseudo-science and not science. Now, if there as an assistant to physicians at the MGH. He is one thing which we who try to do scientifi c joined the MGH as a house pupil and received work should avoid more than another, it is, I his medical degree in 1879, offi cially joining the think this pseudo-scientifi c pretension—the MGH Medical Service after his graduation. He appearance of accuracy expressed in fi gures and fi rst spent a year in Vienna studying pathology, diagrams, when there is no such accuracy in and then returned to MGH in 1882 to start his fact. All blood counts should end with at least career as an Assistant in Pathology and Visiting two zeros, usually three. Physician. At HMS, Dr. Gannett was responsi- Th ere should be no diagnoses made merely ble for the laboratory work in pathological his- in the laboratory, and none merely at the bed- tology. Between 1882 and 1891 he also served as side, unless what are called “laboratory meth- Pathologist at Boston City Hospital and Carney ods” are carried out, as they may be carried out, Hospital. Dr. Gannett was an accomplished and at the bedside. (3) highly regarded diagnostician, and he continued seeing and consulting on patients in addition to In the early twentieth century, therefore, the his laboratory work. role of the laboratory in the clinical diagnosis was Richard C. Cabot (chapter 24) worked on still in question. Most physicians, like Dr. Cabot, blood pathology in collaboration with Dr. James emphasized the power of observation and overall Homer Wright. Dr. Wright’s research included medical knowledge; information from the labora- hematology (chapter 4), and the Wright stain is tory only provided confi rmation of the diagnosis. still used today. In 1894, Dr. Cabot was the fi rst recipient of the Dalton Scholarship and con- Typical Laboratory Workflow: tinued his work on the “minute examination of Early Twentieth Century blood.” During this time, he discovered red cell Laboratory specimens were usually collected by inclusions associated with certain anemias and interns in the fi rst six months of their training. disorders of erythropoiesis that are now termed Urinalysis and blood counts were performed in Cabot rings. His fi rst book, A Guide to the Clini- the ward laboratory under the supervision of the cal Examination of the Blood for Diagnostic Pur- laboratory leadership (“point-of-care testing,” in poses, was published in 1886. today’s lexicon). Orders for blood counts were Dr. Cabot’s career highlights the uncertainty of sent to the central laboratory. An intern was the role of laboratory testing in clinical diagnosis. assigned to collect the samples and perform the He rejected an off er to serve as the fi rst bacteri- counts. In the central laboratory, urgent (stat) ologist of the hospital in favor of a position in the tests were performed by interns on a rotating Outpatient Clinic. Nonetheless, he was an early basis. By today’s standards, the process for report- proponent of providing a specifi c diagnosis to the ing and archiving test results was cumbersome 282 pathology_chap20.indd 282 8/16/11 10:23 AM The Clinical Laboratories (Chemistry and Hematology) and labor-intensive.
Recommended publications
  • The Electrophysiologic Basis for the Antiarrhythmic Effect of N-3 Polyunsaturated Fatty
    The Electrophysiologic Basis for the Antiarrhythmic Effect of n-3 Polyunsaturated Fatty Acids Alexander Leaf Departments of Medicine, Massachusetts General Hospital and the Harvard Medical School, Boston, MA, U.S.A. Short title: Antiarrhythmic and anticonvulsant effects of n-3 fatty acids Send correspondence to: Alexander Leaf, M.D. Massachusetts General Hospital Bldg.149, Rm 4001, 13th Street Charlestown, MA 02129 USA Tel: 617-726-5908 Fax: 617-726-6144 [email protected] 1 Summary - Studies on the antiarrhythmic actions of n-3 polyunsaturated fatty acids in fish oils (PUFA) are reported. The PUFA stabilize the electrical activity of isolated cardiac myocytes by modulating sarcolemmal ion channels, so that a stronger electrical stimulus is required to elicit an action potential and the relative refractory period is markedly prolonged. Inhibition of voltage dependent sodium currents which initiate action potentials in excitable tissues, and also inhibition of the L-type calcium currents, which initiate release of sarcoplasmic calcium stores, that increase cytosolic free calcium concentrations and activate the contractile proteins in myocytes, appear at present to be the probable major antiarrhythmic mechanism of the PUFAs It was the findings of McLennan and Charnock [1], which first conclusively demonstrated in rats that the n-3 fatty acids in fish oils prevented ischemia-induced fatal ventricular arrhythmias. Our studies sought to learn if we could confirm their findings in a reliable dog model of sudden cardiac death with Prof. George E. Billman. A surgically induced myocardial infarction was produced by ligating the left anterior decending coronary artery and an inflatable cuff was placed around the left circumflex artery.
    [Show full text]
  • Intestinal Absorption Christie, DA; Tansey, EM
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Queen Mary Research Online Intestinal absorption Christie, DA; Tansey, EM For additional information about this publication click this link. http://qmro.qmul.ac.uk/jspui/handle/123456789/2800 Information about this research object was correct at the time of download; we occasionally make corrections to records, please therefore check the published record when citing. For more information contact [email protected] Wellcome Witnesses to Twentieth Century Medicine INTESTINAL ABSORPTION A Witness Seminar held at the Wellcome Institute for the History of Medicine, London, on 9 February 1999 Witness Seminar Transcript edited by D A Christie and E M Tansey Introduction by Sir Christopher Booth Volume 8 – September 2000 ©The Trustee of the Wellcome Trust, London, 2000 First published by the Wellcome Trust, 2000 The Wellcome Trust is a registered charity, no. 210183. ISBN 978 184129 017 1 All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/ Please cite as: Christie D A, Tansey E M. (eds) (2000) Intestinal Absorption. Wellcome Witnesses to Twentieth Century Medicine, vol. 8. London: Wellcome Trust. Key Front cover photographs, L to R from the top: Dr Derek Holdsworth Dr Peter Hanson, Dr Richard Boyd Dr Peter Williams, Professor Oliver Wrong Professor Ramsey Bronk, Professor Michael Gardner Lord Turnberg (chair), Professor Timothy Peters Dr Richard Boyd, Professor Ramsey Bronk Dr Sheila Callender (1914–2004), Professor Hermon Dowling Dr Roy Levin, Sir Christopher Booth Back cover photographs, L to R from the top: Professor Hermon Dowling, Sir Christopher Booth Professor Michael Gardner, Dr Peter Hanson, Dr Richard Boyd, Professor Ramsey Bronk Professor John Walker-Smith, Dr George Misiewicz Dr Michael Hellier Professor Roy Pounder Dr George Misiewicz Professor Oliver Wrong CONTENTS Introduction Sir Christopher Booth i Witness Seminars: Meetings and publications ii Transcript 1 List of plates Figure 1.
    [Show full text]
  • Download Selections from the Pharos Autumn
    Alpha Omega Alpha Honor Medical Society Autumn 2014 Rush vs Cobbett THE PHAROS of Alpha Omega Alpha honor medical society Autumn 2014 “Be Worthy to Serve the Suffering” Alpha Omega Alpha Honor Medical Society Founded by William W. Root in 1902 Officers and Directors at Large Editor Richard L. Byyny, MD John Tooker, MD, MBA President Philadelphia, Pennsylvania Editor Emeritus (in memoriam) Robert J. Glaser, MD C. Bruce Alexander, MD Immediate Past President Associate Editor and Helen H. Glaser, MD Birmingham, Alabama Managing Editor Douglas S. Paauw, MD (in memoriam) President-Elect Seattle, Washington Managing Editor Debbie Lancaster Joseph W. Stubbs, MD Secretary-Treasurer Art Director and Illustrator Albany, Georgia Robert G. Atnip, MD Designer Erica Aitken Hershey, Pennsylvania Eve J. Higginbotham, SM, MD Editorial Board Philadelphia, Pennsylvania Richard B. Gunderman, MD, PhD Indianapolis, Indiana Jeremiah A. Barondess, MD Faith T. Fitzgerald, MD Stephen J. McPhee, MD Sheryl Pfeil, MD New York, New York Sacramento, California San Francisco, California Columbus, Ohio David A. Bennahum, MD Daniel Foster, MD Janice Townley Moore Albuquerque, New Mexico Dallas, Texas Young Harris, Georgia Alan G. Robinson, MD John A. Benson, Jr., MD James G. Gamble, MD, PhD Francis A. Neelon, MD Los Angeles, California Portland, Oregon Stanford, California Durham, North Carolina Wiley Souba, MD, DSc, MBA Richard Bronson, MD Dean G. Gianakos, MD William M. Rogoway, MD Hanover, New Hampshire Stony Brook, New York Lynchburg, Virginia Stanford, California Steven A. Wartman, MD, PhD John C.M. Brust, MD Jean D. Gray, MD Shaun V. Ruddy, MD Washington, DC New York, New York Halifax, Nova Scotia Richmond, Virginia Charles S.
    [Show full text]
  • Otto Folin 1867-1934 by Philip Anderson Shaffer
    NATIONAL ACADEMY OF SCIENCES O T T O F OLIN 1867—1934 A Biographical Memoir by PH I L L I P AN D E R S O N S HAFFER Any opinions expressed in this memoir are those of the author(s) and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoir COPYRIGHT 1952 NATIONAL ACADEMY OF SCIENCES WASHINGTON D.C. OTTO FOLIN 1867-1934 BY PHILIP ANDERSON SHAFFER To honor Otto Folin on the twenty-fifth anniversary of his appointment as professor of biological chemistry in Harvard University, after two years as associate professor, a group of his colleagues early in 1934 arranged for the painting of his portrait by an artist of distinction and for its presentation at a gala dinner to be held in the fall to celebrate the event. The death of Folin on October 25 changed that occasion to a memorial meeting held on November 23, at which addresses were made by several of his associates. The portrait by Pollak- Ottendorf was unveiled at that time and now hangs in the library of the Harvard Medical School. It shows in the back- ground a simple instrument and two flasks, an emblem of the colorimetric methods Folin introduced in biochemistry and medicine. This portrait has come to be recognized by his- torians ] as an emblem of progress in a field of which Folin was a pioneer. The portrait is reproduced with this memoir. The address by Henry A. Christian, later printed in Science,2 is a glowing tribute by a friend of many years and excerpts from it constitute a fitting introduction to this memoir.
    [Show full text]
  • Intestinal Absorption
    Wellcome Witnesses to Twentieth Century Medicine INTESTINAL ABSORPTION A Witness Seminar held at the Wellcome Institute for the History of Medicine, London, on 9 February 1999 Witness Seminar Transcript edited by D A Christie and E M Tansey Introduction by Sir Christopher Booth Volume 8 – September 2000 ©The Trustee of the Wellcome Trust, London, 2000 First published by the Wellcome Trust, 2000 The Wellcome Trust is a registered charity, no. 210183. ISBN 978 184129 017 1 All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/ Please cite as: Christie D A, Tansey E M. (eds) (2000) Intestinal Absorption. Wellcome Witnesses to Twentieth Century Medicine, vol. 8. London: Wellcome Trust. Key Front cover photographs, L to R from the top: Dr Derek Holdsworth Dr Peter Hanson, Dr Richard Boyd Dr Peter Williams, Professor Oliver Wrong Professor Ramsey Bronk, Professor Michael Gardner Lord Turnberg (chair), Professor Timothy Peters Dr Richard Boyd, Professor Ramsey Bronk Dr Sheila Callender (1914–2004), Professor Hermon Dowling Dr Roy Levin, Sir Christopher Booth Back cover photographs, L to R from the top: Professor Hermon Dowling, Sir Christopher Booth Professor Michael Gardner, Dr Peter Hanson, Dr Richard Boyd, Professor Ramsey Bronk Professor John Walker-Smith, Dr George Misiewicz Dr Michael Hellier Professor Roy Pounder Dr George Misiewicz Professor Oliver Wrong CONTENTS Introduction Sir Christopher Booth i Witness Seminars: Meetings and publications ii Transcript 1 List of plates Figure 1. The late Professor R B Fisher setting up a demonstration of perfused small intestine. 7 Figure 2. Dr Dennis Parsons, Dr N I McNeil and Professor Leslie Turnberg at the 1983 Falk Symposium on Intestinal Absorption and Secretion in Titisee, Black Forest.
    [Show full text]
  • Effects of Federal Policies on Extracorporeal Shock Wave Lithotripsy (Part 10 Of
    Appendixes Appendix A Acknowledgments and the Health Program Advisory Committee ACKNOWLEDGMENTS The development of this case study was greatly aided by the advice of a number of people. The author and other OTA staff would like to express their appreciation to the advisory panel on Payment for Physician Services: Strategies for Medicare, to the Health Program Advisory Committee, and especially to the following individuals: Henry C. Alder Cynthia P. King American Hospital Association American Medical Association Chicago, IL Chicago, IL Charles R. Booth J. Kersten Kraft Health Care Financing Administration Northern California Kidney Stone Center Baltimore, MD Los Gates, CA Thomas W. Byrne Charles Guidice Blue Cross/Blue Shield of Massachusetts OCHAMPUS Boston, MA Aurora, CO Gary Clisham Frederic C. Jacob Medstone International, Inc. Davis, CA San Diego, CA Gerald Colvin Gerald McDonald Health Systems Agency of Southwestern Veterans Administration Pennsylvania Washington, DC Pittsburgh, PA Robert McDonough Thomas Dolan Duke University Uro-Tech Management Corp. Durham, NC Houston, TX William McGivney George Drach American Medical Association University of Arizona Chicago, IL Tucson, AZ Diane Minear Steven P. Dretler Food and Drug Administration Massachusetts General Hospital Silver Spring, MD Boston, MA Bonnie Grogan Albert G. Mulley Northern California Kidney Stone Center Massachusetts General Hospital Los Gates, CA Boston, MA Harry Heatherington Daniel Newman Health Care Financing Administration Methodist Hospital of Indiana Baltimore, MD Indianapolis, IN Alan Jenkins Eckhard Polzer University of Virginia Medical Center Dornier Medical Systems Inc. Charlottesville, VA Marietta, GA 89 90 Glenn M. Preminger James Snipe University of Texas Health Science Center OCHAMPUS Dallas, TX Aurora, CO Martin I.
    [Show full text]
  • Free, Long-Chain, Polyunsaturated Fatty Acids Reduce Membrane Electrical
    Proc. Natl. Acad. Sci. USA Vol. 92, pp. 3997-4001, April 1995 Physiology Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes (action potential/threshold/automaticity/c3 and w6 fatty acids/antiarrhythmics) JING X. KANG*, YONG-FU XIAO*t, AND ALEXANDER LEAF*t§ *Department of Medicine and the tRenal Unit, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114; and tThe Brockton/West Roxbury Veterans Affairs Medical Center, West Roxbury, MA 02132 Contributed by Alexander Leaf, January 9, 1995 ABSTRACT Because previous studies showed that poly- electrophysiology in neonatal rat cardiac myocytes. We report unsaturated fatty acids can reduce the contraction rate of here that free puFAs, but neither monounsaturated nor sat- spontaneously beating heart cells and have antiarrhythmic urated fatty acids, at 5-10 ,M significantly reduce membrane effects, we examined the effects of the fatty acids on the electrical excitability by increasing the threshold for action electrophysiology of the cardiac cycle in isolated neonatal rat potential (more positive), the resting-membrane potential cardiac myocytes. Exposure of cardiomyocytes to 10 ,lM (more negative), and the refractory-period duration in the eicosapentaenoic acid for 2-5 min markedly increased the cardiac myocytes. strength of the depolarizing current required to elicit an action potential (from 18.0 ± 2.4 pA to 26.8 ± 2.7 pA, P < 0.01) and the cycle length of excitability (from 525 ms to 1225 ms, METHODS AND MATERIALS A = 700 + 212, P < 0.05). These changes were due to an Cell Culture. Cardiac myocytes were isolated from 1-day-old increase in the threshold for action potential (from -52 mV rats using a neonatal cardiomyocyte isolation system (Worth- to -43 mV, A = 9 + 3, P < 0.05) and a more negative resting ington).
    [Show full text]
  • A Century of Healthcare and Medical Education from the Viewpoint of a Clinical Chemist
    A Century of Healthcare and Medical Education from the Viewpoint of a Clinical Chemist By Raymond E. Vanderlinde, PhD Diplomate of the American Board of Clinical Chemistry Emeritus Professor of Pathology and Laboratory Medicine (Division of Clinical Chemistry) and Emeritus Professor of Clinical Biochemistry Hahnemann University School of Medicine (1991) Drexel University School of Medicine (as of 2002) © 2007 by Raymond E. Vanderlinde Catonsville, Maryland Published by the AACC History Division with permission of Dr. Ray Vanderlinde, with minimal editing. 1850 K Street, NW, Suite 625 Washington, DC 20006 Dedication This book is dedicated to Wilfred Wiedy “Weste” Westerfeld, Weste set very high standards and the only one I knowingly PhD, Rhodes Scholar at Oxford University (1938–1940), Harvard failed to achieve was learning to smoke a pipe while doing Medical School Faculty (1940–1945), Chairman and Professor of chemical procedures. As Dr. Westerfeld’s first graduate student Biochemistry at Syracuse University College of Medicine at Syracuse University Medical College, I was the only gradu- (1945–1950), Chairman and Professor of Biochemistry at SUNY ate student to receive his degree in four years and five summers Upstate Medical Center (1950–1979) (successor to SU College of and from Syracuse University. My training prepared me Medicine); Acting Dean SUNY Upstate Medical Center exceedingly well for both a career in academic Biochemistry (1955–1960). and in hospital Clinical Chemistry. Since I was the first of at Weste received his PhD at age 23 under Edward A. Doisey least four of his graduate students who became clinical Sr., PhD, who was Chairman and Professor of Biochemistry at chemists, he was proud of my achievements and leadership in St.
    [Show full text]
  • Supercentenarians Landscape Overview
    Supercentenarians Landscape Overview Top-100 Living Top-100 Longest-Lived Top-25 Socially and Professionally Active GERONTOLOGY RESEARCH GROUP www.aginganalytics.com www.grg.org Supercentenarians Landscape Overview Foreword 3 Top-100 Living Supercentenarians Overview 44 Preface. How Long Can Humans Live and 4 Ages of Oldest Living Supercentenarians by Country 46 the Importance of Age Validation Top-100 Living Supercentenarians Continental Executive Summary 10 47 Distribution by Gender Introduction. 26 Top-100 Living Supercentenarians Distribution by Age 50 All Validated Supercentenarians Сhapter III. Top-25 Socially and Professionally Active All Supercentenarians Region Distribution by Gender 29 52 Living Centenarians Top-25 Socially and Professionally Active Centenarians All Supercentenarians Distribution by Nations 30 53 Overview Top-25 Socially and Professionally Active Centenarians Longest-Lived Supercentenarians Distribution by Country 31 54 Distribution by Nation Top-25 Socially and Professionally Active Centenarians All Supercentenarians Distribution by Gender and Age 32 55 Gender Distribution Top-25 Socially and Professionally Active Centenarians Сhapter I. Top-100 Longest-Lived Supercentenarians 35 56 Distribution by Type of Activity Chapter IV. Profiles of Top-100 Longest-Lived Top-100 Longest-Lived Supercentenarians Overview 36 57 Supercentenarians Top-100 Longest-Lived Supercentenarians Regional 38 Chapter V. Profiles of Top-100 Living Supercentenarians 158 Distribution by Gender Top-100 Longest-Lived Supercentenarians Distribution
    [Show full text]
  • ICC-Book-With-Cover 11-17
    Sir William Osler Image in public domain (PD-1923) THE INTERURBAN CLINICAL CLUB (1905–2015) A RECORD OF ACHIEVEMENT IN CLINICAL AND BIOMEDICAL SCIENCE R John N. Forrest, Jr ACKNOWLEDGMENTSR The following are gratefully acknowledged for contributing financial support for the book. Department chairs: Mark Zeidel Department of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Gary Desir Department of Medicine Yale School of Medicine Donald Landry Department of Medicine Columbia College of Physicians and Surgeons Richard Shannon Former Chair, Department of Medicine Perelman School of Medicine University of Pennsylvania Michael Parmacek Department of Medicine Perelman School of Medicine University of Pennsylvania Myron Weisfeldt Former Chair, Department of Medicine Johns Hopkins School of Medicine Joseph Loscalzo Chair, Department of Medicine Brigham and Women’s Hospital Harvard Medical School Individuals who contributed to the MD-PhD fund: Jonathan Epstein Executive Vice Dean and Chief Scientific Officer Perelman School of Medicine University of Pennsylvania Barbara Kazmierczak MSTP Director Yale School or Medicine I Copyright 2016 The Interurban Clinical Club. Published by the New York Academy of Sciences II DEDICATIONR for Catherine Lee Kiene Forrest III IV GREETINGS FROM THE OSLERR FAMILY The descendants of the Osler family sincerely wish to thank the editor and the active and emeritus members of the Interurban Clinical Club (ICC) for this book that keeps alive the ongoing celebration of the legacy of Sir William Osler as the founder of the club. Medicine is ever changing, but the concept of getting together to hear diverse scientific papers of new findings from the best creative physician-scientists of five east coast cities (Boston, New Ha- ven, New York City, Philadelphia and Baltimore) will never be out of date.
    [Show full text]
  • Protective Effect of Eicosapentaenoic Acid on Ouabain Toxicity in Neonatal Rat Cardiac Myocytes
    Proc. Nati. Acad. Sci. USA Vol. 87, pp. 7834-7838, October 1990 Medical Sciences Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes (cardiac glycoside toxicity/w-3 fatty acid effect/cytosolic calcium overload/cardiac antiarrhythmic/Na,K-ATPase inhibition) HAIFA HALLAQ*t, ALOIS SELLMAYERt, THOMAS W. SMITH§, AND ALEXANDER LEAF* *Department of Preventive Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114; tInstitut fur Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Universitat Munchen, Pettenkofer Strasse 9, 8000 Munich 2, Federal Republic of Germany; and §Cardiovascular Division, Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114 Contributed by Alexander Leaf, June 26, 1990 ABSTRACT Isolated neonatal cardiac myocytes have been sarcolemmal membranes of the heart cells. Furthermore, a utilized as a model for the study of cardiac arrhythmogenic prospective randomized clinical trial (7) showed that, among factors. The myocytes respond to the toxic effects of a potent men who had recently suffered a myocardial infarction, those cardiac glycoside, ouabain at 0.1 mM, by an increase in their that were advised to eat fish two or three times a week had spontaneous beating rate and a reduction in amplitude of a 29% reduction in fatal myocardial infarctions over a sub- contractions resulting within minutes in a lethal state of sequent 2-year period compared to those patients not given contracture. Incubating the isolated myocytes for 3-S5 days in such advice. There was, however, no significant difference in culture medium enriched with 5 ,IM arachidonic acid [20:4 cardiac events; those eating fish just did not die as frequently (n-6)] had no effect on the development of lethal contracture of their myocardial infarctions.
    [Show full text]
  • Dennis G. Maki, M.D. June 2015
    Dennis G. Maki, M.D. June 2015 Dr. Maki is the Ovid O. Meyer Professor of Medicine in the Divisions of Infectious Diseases and Pulmonary-Critical Care Medicine at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin, attending physician in the UWHC Center for Trauma and Life Support and eICU, and former Head of the Division of Infectious Diseases 1979 through 2007. Dr Maki, a 1967 graduate of the University of Wisconsin School of Medicine and Public Health, did his internal medicine residency training on the Harvard Medical Service of the Boston City Hospital, where he was the Chief Resident, and the Massachusetts General Hospital, where he also did his fellowship in infectious diseases, and during this period spent two years as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention. An infectious disease consultant, critical care physician and epidemiologist, he has devoted his research career to the prevention of nosocomial infections and management of life-threatening infections, and has published more than 350 original papers, editorials, chapters and reviews and 700 abstracts of research presented at national or international scientific meetings; his publications have been cited by other researchers more than 16,000 times and provide much of the scientific underpinning for the “bundle” of measures currently employed for prevention of line sepsis in hospitals worldwide. A past consultant to the CDC, NIH, FDA, HHS, GAO and the UK NHS, he is former President of the Society for Healthcare Epidemiology of America and Councillor of the Infectious Diseases Society of America.
    [Show full text]